Clinical Trials Directory

Trials / Completed

CompletedNCT01599468

Can Tranexamic Acid Reduce Bleeding After Post Partum Hemorrhage in Cesarean Section Delivery

Effects of Tranexamic Acid on Post Partum Hemorrhage by Uterine Atony After Cesarean Section Delivery: a Randomized, Placebo Controlled Trial.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
74 (actual)
Sponsor
Hédi Chaker Hospital · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to evaluate the effect of early administration of tranexamic acid (TXA) on post partum hemorrhage caused by uterine atony after cesarean section delivery. This was a randomised, placebo controlled trial including 74 patients. The investigators included ASA1 parturients with correct haemostatic status undergoing cesarean section under spinal anesthesia. The randomization begins after the inefficacy of oxytocin injections and starting up sulprostone perfusion at the request of the surgeon. TXA Group received 10 mg/kg of tranexamic acid as induction dose within 12 minutes and 1mg/Kg/h as maintenance within the 2 following hours. Placebo Group received same volumes of normal saline. The investigators compared blood loss and transfusions in both groups.

Conditions

Interventions

TypeNameDescription
DRUGTranexamic Acid10 mg/kg of tranexamic acid as induction dose within 12 minutes and 1mg/Kg/h as maintenance within the 2 following hours
DRUGsaline serumThe Placebo group received normal saline with the same volumes

Timeline

Start date
2011-07-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2012-05-16
Last updated
2012-05-22

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT01599468. Inclusion in this directory is not an endorsement.